OpenAI Acquires Orchestra Bio to Expand Life Sciences AI Capabilities
OpenAI has acquired startup Orchestra Bio to strengthen its biotechnology division and advance Rosalind, its specialized AI model for life sciences research. The acquisition integrates Orchestra's team and technology into the Rosalind Workbench, providing researchers with advanced tools to plan experiments and analyze complex scientific results.
Source: TechCrunch